Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Chemogenetic ON and OFF switches for RNA virus replication.

Nature communications·2021
Same author

Miniature integrated micro-spectrometer array for snap shot multispectral sensing.

Optics express·2019
Same author

Technical note: Validation of a semi-automated software tool to determine gait-cycle variables in dairy cows.

Journal of dairy science·2017
Same author

Disease type-associated increases of the plasma levels and ligand expression for natural alpha- or beta-galactoside-binding immunoglobulin G subfractions in patients with lung cancer.

International journal of oncology·2011
Same author

Spectroscopic measurements with dispersion encoded full range frequency domain optical coherence tomography in single- and multilayered non-scattering phantoms.

Optics express·2010
Same author

Experience with unipolar pectoral defibrillation.

Herzschrittmachertherapie & Elektrophysiologie·2009

Video Experimental Relacionado

Updated: Jul 14, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
16:40

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

Published on: February 28, 2012

Experiencia clínica con un dispositivo antiarrítmico multiprogramable de terapia por niveles y un dispositivo

G H Bardy1, C Troutman, J E Poole

  • 1Department of Medicine, University of Washington, Seattle.

Circulation
|May 1, 1992
PubMed
Resumen

Un nuevo dispositivo antiarritmia multiprogramable mejoró significativamente los resultados para los sobrevivientes de paro cardíaco. Esta terapia avanzada redujo los choques y el uso de drogas, mejorando la supervivencia del paciente y la calidad de vida.

Más Videos Relacionados

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder
05:19

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder

Published on: July 7, 2023

Videos de Experimentos Relacionados

Last Updated: Jul 14, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
16:40

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

Published on: February 28, 2012

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder
05:19

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder

Published on: July 7, 2023

Área de la Ciencia:

  • Cardiología Cardiología.
  • Electrofisiología y electrofisiología.
  • Dispositivos Médicos Dispositivos Médicos para el Cuerpo

Sus antecedentes:

  • Los sobrevivientes de un paro cardíaco a menudo se enfrentan a arritmias ventriculares potencialmente mortales.
  • Los dispositivos antiarrítmicos tradicionales tienen limitaciones en el manejo de arritmias complejas.

Objetivo del estudio:

  • Para evaluar la experiencia clínica inicial con un nuevo dispositivo antiarritmico multiprogramable.
  • Para evaluar la eficacia del dispositivo en los sobrevivientes de un paro cardíaco.

Principales métodos:

  • Se implantó un dispositivo antiarritmico multiprogramable en 50 sobrevivientes de un paro cardíaco.
  • Utilizó terapia escalonada y criterios de detección variables para el manejo de la arritmia.
  • Empleado ambos sistemas de plomo epicárdico y transvenoso.

Principales resultados:

  • Se logró una supervivencia del 96% de los pacientes durante un seguimiento de 15 meses, sin muertes por arritmia.
  • Se redujo el uso de medicamentos antiarrítmicos en el 82% de los pacientes y se evitaron los marcapasos de bradicardia en el 18%.
  • Permitió pruebas electrofisiológicas no invasivas, evitando procedimientos invasivos en 35 pacientes.

Conclusiones:

  • El dispositivo multiprogramable representa un avance significativo en el tratamiento de las arritmias ventriculares.
  • Minimiza los choques dolorosos, reduce la dependencia de los medicamentos y simplifica la evaluación electrofisiológica.
  • Ofrece mejores resultados de los pacientes y calidad de vida para aquellos con arritmias que ponen en peligro la vida.